HighTower Advisors’s Merck MRK Stock Holding History

HighTower Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,000	Closed	-$5.46K	–	3974
2025 Q2	$5.46K	Buy	4,000 +3,500	+700%	+$278K	﹤0.01%	3671
2025 Q1	$1.42K	Sell	500 -4,500	-90%	-$420K	﹤0.01%	3641
2024 Q4	$2.08K	Buy	5,000 +4,600	+1,150%	+$474K	﹤0.01%	3681
2024 Q3	$439	Buy	+400	New	+$47.5K	﹤0.01%	3691
2022 Q2	–	Sell	-2	Closed	-$1K	–	3434
2022 Q1	$1K	Buy	+2	New	+$158	﹤0.01%	3369
2021 Q3	–	Sell	-2,000	Closed	-$6K	–	3339
2021 Q2	$6K	Buy	+2,000	New	+$149K	﹤0.01%	3026
2020 Q4	–	Sell	-3,878	Closed	-$3K	–	2745
2020 Q3	$3K	Buy	3,878 +3,668	+1,747%	+$287K	﹤0.01%	2487
2020 Q2	$1K	Buy	+210	New	+$15.8K	﹤0.01%	2409
2018 Q3	–	Sell	-4,192	Closed	-$6K	–	2374
2018 Q2	$6K	Buy	+4,192	New	+$236K	﹤0.01%	2170
2014 Q2	–	Sell	-524	Closed	-$4K	–	1673
2014 Q1	$4K	Buy	+524	New	+$27.1K	﹤0.01%	1543

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HighTower Advisors's MRK Position: Q2 2026 in Review

HighTower Advisors increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $5.21M and bringing the position to 3,679,920 shares worth $473M. The position accounts for 0.45% of the portfolio, ranked #40.

HighTower Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

HighTower Advisors held 3,679,920 shares of Merck worth $473M as of Q2 2026.
HighTower Advisors bought 44,516 Merck shares in Q2 2026, an estimated $5.21M.
Merck made up 0.45% of HighTower Advisors's portfolio in Q2 2026, its #40 holding.
HighTower Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.